Bayview Pharmacy's compounded formulation of Ketamine HCl 10%/Gabapentin 6%/Lidocaine 5%/Baclofen 2%/Cyclobenzaprine HCl 2% Topical Gel is a specialized blend of medications designed to address a range of chronic pain conditions. This unique formulation is specifically tailored to provide relief for conditions such as Fibromyalgia, Neuropathic Pain, Muscle Spasms, Chronic Pain, and Migraine.

The topical gel is a semisolid formulation dispensed through a pump mechanism, facilitating easy and precise application on the skin for targeted treatment. The gel-like consistency allows for the efficient absorption of the active ingredients directly at the site of pain, providing localized relief.

Each component of this formulation plays a crucial role in pain management. Ketamine HCl, a well-established anesthetic, works by blocking the transmission of pain signals to the brain, thereby reducing the perception of pain. Gabapentin, an anticonvulsant, is effective in treating neuropathic pain and fibromyalgia. Lidocaine, a local anesthetic, aids in reducing pain and inflammation at the site of application.

Baclofen and Cyclobenzaprine HCl, both muscle relaxants, contribute to the reduction of muscle spasms and improvement of mobility. The combined effect of these medications in the formulation provides a comprehensive approach to pain management, potentially improving the quality of life for those suffering from chronic pain conditions.

This compounded formulation is a testament to the potential of targeted, personalized medication in managing chronic pain. If you have any questions about this formulation or how it may be beneficial in treating your specific condition, please do not hesitate to contact us. We are committed to providing effective solutions for your health needs.

This compounded formulation of Ketamine HCl 10%/Gabapentin 6%/Lidocaine 5%/Baclofen 2%/Cyclobenzaprine HCl 2% is a topical gel designed for targeted treatment of various pain conditions. It is dispensed through a pump mechanism, which allows for easy and precise application on the skin. The gel-like consistency aids in the absorption of the active ingredients.

The formulation is indicated for the treatment of Fibromyalgia, Neuropathic Pain, Muscle Spasms, Chronic Pain, and Migraine. The combination of these medications has been shown to provide effective relief of pain and spasms, as well as reduce inflammation.

Ketamine HCl is an NMDA receptor antagonist that has been shown to reduce pain and improve mood in patients with Fibromyalgia. Gabapentin is an anticonvulsant that has been shown to reduce neuropathic pain and improve sleep in patients with Fibromyalgia. Lidocaine is a local anesthetic that has been shown to reduce pain and improve function in patients with Neuropathic Pain. Baclofen is a muscle relaxant that has been shown to reduce muscle spasms and improve function in patients with Muscle Spasms. Cyclobenzaprine HCl is a muscle relaxant that has been shown to reduce muscle spasms and improve function in patients with Chronic Pain and Migraine.

It is important to note that this formulation may interact with other medications. Therefore, patients should inform their healthcare provider of all medications they are taking before using this formulation. Potential side effects may include, but are not limited to, drowsiness, dizziness, nausea, and headache.

If you have any questions about this formulation or its use, please consult with your healthcare provider. It is crucial to use this medication as directed by a healthcare professional to ensure its effectiveness and to minimize potential risks.

This compounded formulation is a topical gel that combines five active ingredients: Ketamine HCl 10%, Gabapentin 6%, Lidocaine 5%, Baclofen 2%, and Cyclobenzaprine HCl 2%. Each ingredient plays a crucial role in managing various conditions such as fibromyalgia, neuropathic pain, muscle spasms, chronic pain, and migraines. Ketamine HCl and Lidocaine work in tandem to alleviate pain and inflammation. Gabapentin is effective in reducing nerve pain. Baclofen aids in muscle relaxation and reducing spasms, while Cyclobenzaprine HCl further assists in mitigating muscle spasms and pain. This synergistic blend of medications aims to provide relief from pain, inflammation, and muscle spasms associated with these conditions.

When using this topical gel, it is essential to adhere to the instructions provided by your healthcare provider. The gel should be applied to the affected area as directed, avoiding contact with the eyes, nose, and mouth. In case of accidental contact, rinse the area thoroughly with water. It is also crucial to avoid applying the gel on broken or irritated skin.

While this topical gel is designed for targeted treatment, it may cause side effects such as skin irritation, redness, itching, burning, or stinging. If you experience any of these side effects, it is recommended to contact your healthcare provider immediately. Furthermore, this medication may interact with other medications you are currently taking. Therefore, it is important to discuss your complete medication list with your healthcare provider before starting this topical gel treatment.

If you have any queries or concerns about this topical gel or its mechanism of action, please do not hesitate to contact us. We are here to assist you in understanding your medication better.

This compounded formulation of Ketamine HCl 10%, Gabapentin 6%, Lidocaine 5%, Baclofen 2%, and Cyclobenzaprine HCl 2% in a topical gel form is designed for targeted treatment and absorption of active ingredients. The semisolid formulation is dispensed through a pump mechanism, allowing for easy and precise application on the skin. It has been effectively used in the management of various pain conditions including Fibromyalgia, Neuropathic Pain, Muscle Spasms, Chronic Pain, and Migraine. It has also shown efficacy in treating other conditions such as chronic low back pain, post-herpetic neuralgia, and complex regional pain syndrome.

One of the significant benefits of this formulation is its potential to reduce the need for opioid analgesics in patients with chronic pain, thereby minimizing the risk of opioid dependency. It has been observed to reduce the intensity of pain and improve the quality of life in patients with chronic pain conditions. As with any medication, it is essential that this formulation is used as directed by a healthcare provider. Patients should be monitored for any adverse effects and should immediately contact their healthcare provider if any occur. This formulation has been found to be safe and effective when used appropriately.